These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23934147)

  • 1. Do meta-analyses reveal time-dependent differences between the clinical outcomes achieved by microfracture and autologous chondrocyte implantation in the treatment of cartilage defects of the knee?
    Negrin LL; Vécsei V
    J Orthop Sci; 2013 Nov; 18(6):940-8. PubMed ID: 23934147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome of autologous chondrocyte implantation for failed microfracture treatment of full-thickness cartilage defects of the knee joint.
    Pestka JM; Bode G; Salzmann G; Südkamp NP; Niemeyer P
    Am J Sports Med; 2012 Feb; 40(2):325-31. PubMed ID: 22056348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of cartilage defects in the knee joint: microfracture, mosaicplasty, and autologous chondrocyte implantation.
    Rodríguez-Merchán EC
    Am J Orthop (Belle Mead NJ); 2012 May; 41(5):236-9. PubMed ID: 22715442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NeoCart, an autologous cartilage tissue implant, compared with microfracture for treatment of distal femoral cartilage lesions: an FDA phase-II prospective, randomized clinical trial after two years.
    Crawford DC; DeBerardino TM; Williams RJ
    J Bone Joint Surg Am; 2012 Jun; 94(11):979-89. PubMed ID: 22637204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arthroscopic second-generation autologous chondrocyte implantation compared with microfracture for chondral lesions of the knee: prospective nonrandomized study at 5 years.
    Kon E; Gobbi A; Filardo G; Delcogliano M; Zaffagnini S; Marcacci M
    Am J Sports Med; 2009 Jan; 37(1):33-41. PubMed ID: 19059899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity levels are higher after osteochondral autograft transfer mosaicplasty than after microfracture for articular cartilage defects of the knee: a retrospective comparative study.
    Krych AJ; Harnly HW; Rodeo SA; Williams RJ
    J Bone Joint Surg Am; 2012 Jun; 94(11):971-8. PubMed ID: 22637203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, randomized clinical study of osteochondral autologous transplantation versus microfracture for the treatment of osteochondritis dissecans in the knee joint in children.
    Gudas R; Simonaityte R; Cekanauskas E; Tamosiūnas R
    J Pediatr Orthop; 2009; 29(7):741-8. PubMed ID: 20104156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous chondrocyte implantation in chondral defects of the knee with a type I/III collagen membrane: a prospective study with a 3-year follow-up.
    Steinwachs M; Kreuz PC
    Arthroscopy; 2007 Apr; 23(4):381-7. PubMed ID: 17418330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective multicenter study on the outcome of type I collagen hydrogel-based autologous chondrocyte implantation (CaReS) for the repair of articular cartilage defects in the knee.
    Schneider U; Rackwitz L; Andereya S; Siebenlist S; Fensky F; Reichert J; Löer I; Barthel T; Rudert M; Nöth U
    Am J Sports Med; 2011 Dec; 39(12):2558-65. PubMed ID: 21984690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of symptomatic cartilage defects of the knee: characterized chondrocyte implantation results in better clinical outcome at 36 months in a randomized trial compared to microfracture.
    Saris DB; Vanlauwe J; Victor J; Almqvist KF; Verdonk R; Bellemans J; Luyten FP;
    Am J Sports Med; 2009 Nov; 37 Suppl 1():10S-19S. PubMed ID: 19846694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year outcome of characterized chondrocyte implantation versus microfracture for symptomatic cartilage defects of the knee: early treatment matters.
    Vanlauwe J; Saris DB; Victor J; Almqvist KF; Bellemans J; Luyten FP;
    Am J Sports Med; 2011 Dec; 39(12):2566-74. PubMed ID: 21908720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and cost-effectiveness of autologous chondrocyte implantation for cartilage defects in knee joints: systematic review and economic evaluation.
    Clar C; Cummins E; McIntyre L; Thomas S; Lamb J; Bain L; Jobanputra P; Waugh N
    Health Technol Assess; 2005 Dec; 9(47):iii-iv, ix-x, 1-82. PubMed ID: 16336842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten-year follow-up of a prospective, randomized clinical study of mosaic osteochondral autologous transplantation versus microfracture for the treatment of osteochondral defects in the knee joint of athletes.
    Gudas R; Gudaite A; Pocius A; Gudiene A; Cekanauskas E; Monastyreckiene E; Basevicius A
    Am J Sports Med; 2012 Nov; 40(11):2499-508. PubMed ID: 23024150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CaReS (MACT) versus microfracture in treating symptomatic patellofemoral cartilage defects: a retrospective matched-pair analysis.
    Petri M; Broese M; Simon A; Liodakis E; Ettinger M; Guenther D; Zeichen J; Krettek C; Jagodzinski M; Haasper C
    J Orthop Sci; 2013 Jan; 18(1):38-44. PubMed ID: 23001127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Articular cartilage treatment in high-level male soccer players: a prospective comparative study of arthroscopic second-generation autologous chondrocyte implantation versus microfracture.
    Kon E; Filardo G; Berruto M; Benazzo F; Zanon G; Della Villa S; Marcacci M
    Am J Sports Med; 2011 Dec; 39(12):2549-57. PubMed ID: 21900624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved outcomes with combined autologous chondrocyte implantation and patellofemoral osteotomy versus isolated autologous chondrocyte implantation.
    Trinh TQ; Harris JD; Siston RA; Flanigan DC
    Arthroscopy; 2013 Mar; 29(3):566-74. PubMed ID: 23312875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current treatments of isolated articular cartilage lesions of the knee achieve similar outcomes.
    Lim HC; Bae JH; Song SH; Park YE; Kim SJ
    Clin Orthop Relat Res; 2012 Aug; 470(8):2261-7. PubMed ID: 22422593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous chondrocyte implantation for full thickness articular cartilage defects of the knee.
    Vasiliadis HS; Wasiak J
    Cochrane Database Syst Rev; 2010 Oct; 2010(10):CD003323. PubMed ID: 20927732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of autologous chondrocyte implantation in patients with failed prior treatment for articular cartilage defect of the knee: results of the Study of the Treatment of Articular Repair (STAR) clinical trial.
    Zaslav K; Cole B; Brewster R; DeBerardino T; Farr J; Fowler P; Nissen C;
    Am J Sports Med; 2009 Jan; 37(1):42-55. PubMed ID: 18927254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture.
    Saris DB; Vanlauwe J; Victor J; Haspl M; Bohnsack M; Fortems Y; Vandekerckhove B; Almqvist KF; Claes T; Handelberg F; Lagae K; van der Bauwhede J; Vandenneucker H; Yang KG; Jelic M; Verdonk R; Veulemans N; Bellemans J; Luyten FP
    Am J Sports Med; 2008 Feb; 36(2):235-46. PubMed ID: 18202295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.